Should You Always Finish Your Antibiotics? New Study Challenges Old Advice
Nearly 90% of adults in the United States believe that finishing every prescribed antibiotic is always best, even after symptoms resolve, according to a national survey published in the journal Open Forum Infectious Diseases. Led by researchers at University of Utah Health, the study reveals a disconnect between modern clinical guidelines and enduring public health messaging regarding bacterial infection treatments.
- A national study of 1,475 adults found that 88% had heard of, and agreed with, the mantra to “always finish their antibiotic course.”
- Clinical evidence demonstrates that shorter courses are often safer and equally effective for many conditions, such as a three- to five-day course for pneumonia.
- Researchers recommend that clinicians engage in individualized discussions regarding precise treatment durations rather than relying on blanket adherence rules.
The study, titled “US Adults’ Perspectives on Antibiotic Durations and Adherence to Therapy for Common Bacterial Respiratory Infections: A National Survey,” surveyed 1,475 participants nationwide to evaluate public attitudes toward antibiotic course length. According to Alistair Thorpe, the study’s lead author and a research assistant professor of population health sciences at University of Utah Health, past mandates from prominent health institutions placed significant weight on the consumption of every last pill. According to Thorpe, a growing body of clinical evidence now indicates that shorter treatment durations frequently match the efficacy and safety of longer regimens, and are less likely to cause side effects.
Despite these evolving protocols, the survey uncovered that roughly 60% of respondents would still prefer a week-long or longer course of antibiotics for pneumonia, despite current guidelines recommending a condensed three- to five-day window. The primary driver behind this preference is adherence to the traditional mantra to “always finish your antibiotic course,” which 88% of participants recognized and endorsed. Most respondents reported receiving this advice directly from their healthcare clinicians or through public health campaigns.
While shorter courses benefit many common bacterial infections, medical science continues to recognize exceptions. According to the research team, conditions such as tuberculosis require longer courses to be most effective. The findings suggest that public health messaging and bedside consultations must shift away from overly simplistic binaries—such as asserting that shorter or longer courses are universally superior—and instead embrace the evolving nature of medical evidence.
To bridge this communication gap, Thorpe recommends that patients diagnosed with bacterial infections maintain an open dialogue with their prescribing physicians. Discussing specific clinical variables and determining the precise point to safely discontinue medication ensures individualized care.
Support for this research was provided by the American Heart Association, the medicine department at the University of Alabama at Birmingham, internal research funds from the internal medicine department at the University of Utah, and the Jon M. Huntsman Presidential Endowed Chair of the population health sciences department at the University of Utah. Authors emphasize that shifting guidelines reflect normal scientific progress, underscoring the ongoing effort to improve how care is provided.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.